Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA approves Hycamtin as second-line treatment of small cell lung cancer

Dec. 4, 1998

Maxia initiates pivotal phase III trial with MX-6 for treatment of CIN

Dec. 4, 1998

Accutin, an RGD-containing peptide with angiogenesis-inhibitory activity

Dec. 3, 1998

Adozelesin displays marginal efficacy in previously untreated metastatic breast cancer

Dec. 3, 1998

IntraBiotics receives milestone payment from Pharmacia & Upjohn

Dec. 3, 1998

Lack of cardiotoxicity of SM-5887 confirmed in dogs

Dec. 2, 1998

Taisho discloses new antitumor series

Dec. 2, 1998

Inhibitors of neovascularization (angiogenesis) patented by JT

Dec. 2, 1998

Vical reports delivery of cytokine and antitumor activity using naked DNA gene transfer

Dec. 1, 1998

Phase II prostate cancer trial of Atragen now in progress

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...